NCT06588504View on ClinicalTrials.gov

Research Study in Japan to Compare Dasiglucagon With Glucagon in Treating Very Low Levels of Blood Sugar in Asian Adults With Type 1 Diabetes and Testing of Dasiglucagon for the Same Condition in Japanese Adolescents

PHASE1CompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

September 10, 2024

Primary Completion Date

June 24, 2025

Study Completion Date

July 20, 2025

Conditions
Diabetes Mellitus, Type 1
Interventions
DRUG

Dasiglucagon

Participants will receive s.c. injection of dasiglucagon.

DRUG

Glucagon

Participants will receive i.m. injection of glucagon.

Trial Locations (1)

812-0025

Hakata Clinic, Fukuoka

Sponsors

Lead Sponsor

Novo Nordisk A/S
All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY

NCT06588504 - Research Study in Japan to Compare Dasiglucagon With Glucagon in Treating Very Low Levels of Blood Sugar in Asian Adults With Type 1 Diabetes and Testing of Dasiglucagon for the Same Condition in Japanese Adolescents | Biotech Hunter | Biotech Hunter